查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405874

透明質酸市場規模、佔有率、趨勢分析報告：按應用、地區、細分市場預測，2024-2030

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

透明質酸市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，預計2030年全球透明質酸市場規模將達167.5億美元，2024年至2030年複合年成長率為7.7%。

大眾對化學品的興趣增加、渴望獲得快速、明顯的結果以及更快的恢復時間等因素是影響深遠的渲染促進因素。由於已開發國家和發展中國家擴大採用美容手術，該行業正在迅速發展。為了改善貼合度，透明質酸表面在心血管植入（如支架和血管移植物）中的使用越來越多，再加上抗老化產品的認知不斷增強，這正在推動成長。

基於透明質酸的真皮填充劑的有效性和明顯效果吸引了這一人群。此外，COVID-19大流行改變了許多行業的動態，旅行限制、社交距離和修改做法成為「新常態」。隨著化妝品行業逐漸重新開放，許多醫生報告說，有關整容手術的詢問大幅增加。此外，國家隔離導致專業人士使用視訊會議設備，人們對自己的外表變得更加在意。在某些情況下，人們會選擇美容治療，這被稱為「變焦熱潮」或「變焦效應」。

受疫情影響，世界各地的整形外科醫生的患者數量大幅增加，尤其是在美國、澳洲和日本等國家。 2022 年，北美地區佔據最大的銷售佔有率。儘管價格高，但對短期治療方法的偏好以及骨關節炎等目標疾病的流行是導致高市佔率的主要因素。 2022 年，北美地區最受歡迎的產品應用是型態治療骨關節炎的真皮填充劑和黏膠補充品。預計亞太地區在預測期內複合年成長率最快。

中國和日本的老年人口不斷成長，成為抗老化產品和服務的龐大基本客群。對產品用途和功效的認知不斷提高也推動了需求。此外，可支配收入水準的上升進一步支持了該地區的擴張。過去兩年，歐洲發生了顯著變化。不斷擴大的需求正在加劇新參與企業的價格競爭。世界衛生組織最近宣布英國和德國肥胖流行。人口高齡化與肥胖之間的關係是歐洲區域部門的潛在驅動力。

透明質酸市場報告亮點

  • 骨關節炎領域在全球產業中佔據主導地位，並在 2023 年佔總收益的最大佔有率。
  • 肥胖引起的骨關節炎和關節疼痛的增加增加了注射透明質酸作為治療方法的需求。
  • 透明質酸可作為減震器和緩衝墊，潤滑關節並幫助它們正常運作。
  • 有許多眼科手術產品含有透明質酸/透明質酸作為活性成分。
  • 其中包括 Vitrax、Healon、Amvisco Plus、Amvisc、Hylan G-F20 和 Opegan。
  • 與老齡化相關的眼科疾病、乾眼症候群、成人視力障礙和糖尿病等慢性疾病的盛行率不斷上升，是引導該細分市場成長的主要因素。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章透明質酸市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 玻尿酸市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 透明質酸市場：應用預估及趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 全球透明質酸市場按應用前景
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 真皮填充劑
    • 骨關節炎
    • 眼科
    • 膀胱輸尿管逆流症

第5章 玻尿酸市場：區域預估及趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
  • 供應商形勢
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023 年主要企業股票分析
    • Allergan
    • Sanofi
    • Genzyme Corporation
    • Anika Therapeutics, Inc.
    • Salix Pharmaceuticals
    • Seikagaku Corporation
    • F. Hoffmann-La Roche Ag
    • Galderma Laboratories LP
    • Zimmer Biomet
    • Smith &Nephew Plc
    • Ferring BV
    • Lifecore Biomedical, LLC
    • HTL Biotechnology
    • Shiseido Company, Limited
    • Bloomage Biotechnology Corporation Limited
    • LG Life Sciences Ltd（LG Chem.）
    • Maruha Nichiro, Inc.
Product Code: 978-1-68038-333-1

Hyaluronic Acid Market Growth & Trends:

The global hyaluronic acid market size is expected to reach USD 16.75 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect."

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights:

  • The osteoarthritis segment dominated the global industry and accounted for the maximum share of the overall revenue in 2023
  • The rising obesity resulting in osteoarthritis and joint pain has increased the demand for hyaluronic acid injections as a treatment
  • Hyaluronic acid acts as a shock absorber or a cushion and lubricates the joints, thus helping in proper functioning
  • There are a number of ophthalmic surgical products that use hyaluronan/hyaluronic acid as an active ingredient
  • These include Vitrax, Healon, Amivisc Plus, Amvisc, Hylan G-F20, and Opegan
  • The increasing prevalence of age-related eye diseases, dry eye syndrome, adult-vision impairments, and chronic diseases, such as diabetes, are major factors leading to segment growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing Geriatric Population
      • 3.2.1.2. Growing Awareness for Antiaging Products
      • 3.2.1.3. High Prevalence of Target Diseases
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Associated adverse effects of hyaluronic acid
      • 3.2.2.2. High cost of products and related services
  • 3.3. Hyaluronic Acid Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Hyaluronic Acid Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
    • 4.4.1. Dermal fillers
      • 4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Osteoarthritis
      • 4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.2.2. Single-injection
      • 4.4.2.2.1 Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.2.3. Three-injection
      • 4.4.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.2.3. Five-injection
      • 4.4.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Ophthalmic
      • 4.4.3.3. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.4. Vesicoureteral reflux
      • 4.4.2.3. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.3. France
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.4. Italy
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.5. Spain
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.6. Norway
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.7. Sweden
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework/ reimbursement structure
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.6.8. Denmark
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework/ reimbursement structure
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework/ reimbursement structure
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.8.2. Mexico
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework/ reimbursement structure
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework/ reimbursement structure
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework/ reimbursement structure
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework/ reimbursement structure
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2023
    • 6.3.4. Allergan
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Sanofi
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Genzyme Corporation
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Anika Therapeutics, Inc.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Salix Pharmaceuticals
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Seikagaku Corporation
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. F. Hoffmann-La Roche Ag
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Galderma Laboratories L.P.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Zimmer Biomet
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Smith & Nephew Plc
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. Ferring B.V.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Lifecore Biomedical, LLC
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. HTL Biotechnology
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives
    • 6.3.17. Shiseido Company, Limited
      • 6.3.17.1. Company overview
      • 6.3.17.2. Financial performance
      • 6.3.17.3. Product benchmarking
      • 6.3.17.4. Strategic initiatives
    • 6.3.18. Bloomage Biotechnology Corporation Limited
      • 6.3.18.1. Company overview
      • 6.3.18.2. Financial performance
      • 6.3.18.3. Product benchmarking
      • 6.3.18.4. Strategic initiatives
    • 6.3.19. LG Life Sciences Ltd (LG Chem.)
      • 6.3.19.1. Company overview
      • 6.3.19.2. Financial performance
      • 6.3.19.3. Product benchmarking
      • 6.3.19.4. Strategic initiatives
    • 6.3.20. Maruha Nichiro, Inc.
      • 6.3.20.1. Company overview
      • 6.3.20.2. Financial performance
      • 6.3.20.3. Product benchmarking
      • 6.3.20.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 5 Canada Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 6 Europe Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 8 Germany Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 9 UK Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 10 France Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 11 Italy Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 12 Spain Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 13 Denmark Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 14 Sweden Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 15 Norway Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 18 China Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 19 Japan Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 20 India Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 21 South Korea Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 22 Australia Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 23 Thailand Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 24 Latin America Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 26 Brazil Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 27 Mexico Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 28 Argentina Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 29 MEA Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 31 South Africa Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 33 UAE Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Hyaluronic Acid market: market outlook
  • Fig. 14 Hyaluronic Acid competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Hyaluronic Acid market driver impact
  • Fig. 20 Hyaluronic Acid market restraint impact
  • Fig. 21 Hyaluronic Acid market strategic initiatives analysis
  • Fig. 22 Hyaluronic Acid market: Application movement analysis
  • Fig. 23 Hyaluronic Acid market: Application outlook and key takeaways
  • Fig. 24 Dermal fillers market estimates and forecast, 2018 - 2030
  • Fig. 25 Osteoarthritis market estimates and forecast, 2018 - 2030
  • Fig. 26 Single-injection market estimates and forecast, 2018 - 2030
  • Fig. 27 Three-injection market estimates and forecast, 2018 - 2030
  • Fig. 28 Five-injection market estimates and forecast, 2018 - 2030
  • Fig. 29 Ophthalmic market estimates and forecast, 2018 - 2030
  • Fig. 30 Vesicoureteral reflux market estimates and forecast, 2018 - 2030
  • Fig. 31 Global Hyaluronic Acid market: Regional movement analysis
  • Fig. 32 Global Hyaluronic Acid market: Regional outlook and key takeaways
  • Fig. 33 Global Hyaluronic Acid market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America, by country
  • Fig. 45 North America
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030
  • Fig. 47 U.S.
  • Fig. 48 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 49 Canada
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 51 Europe
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 53 UK
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030
  • Fig. 55 Germany
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 57 France
  • Fig. 58 France market estimates and forecasts, 2018 - 2030
  • Fig. 59 Italy
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 61 Spain
  • Fig. 62 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 63 Denmark
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 65 Sweden
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 67 Norway
  • Fig. 68 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 71 China
  • Fig. 72 China market estimates and forecasts, 2018 - 2030
  • Fig. 73 Japan
  • Fig. 74 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 75 India
  • Fig. 76 India market estimates and forecasts, 2018 - 2030
  • Fig. 77 Thailand
  • Fig. 78 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 79 South Korea
  • Fig. 80 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 81 Australia
  • Fig. 82 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 83 Latin America
  • Fig. 84 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 85 Brazil
  • Fig. 86 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 87 Mexico
  • Fig. 88 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 89 Argentina
  • Fig. 90 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 91 Middle East and Africa
  • Fig. 92 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 93 South Africa
  • Fig. 94 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 95 Saudi Arabia
  • Fig. 96 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 97 UAE
  • Fig. 98 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 99 Kuwait
  • Fig. 100 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 101 Market share of key market players- Hyaluronic Acid market